Stock listing

Lang & Schwarz:862449 Bio-Rad Laboratories, Inc. Aktie

German listing (Lang & Schwarz) of Bio-Rad Laboratories, Inc. · home listing NYSE:BIO

Follow Bio-Rad Laboratories, Inc. into a list and get an email when it puts out news.

Home listing price · NYSE:BIO

$358.90 USD -11.27 (-3.0%)

Close on Nov 20, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NYSE:BIO

Past year +18.2% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
$353.31 – $369.44 USDNov 20, 2026
Volume
182,296 sharesNov 20, 2026
Market cap
$7.84B USDAt the close on Nov 20, 2026 · price × 21.83M shares outstanding
52-week range
$236.73 – $396.23 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
$96.59M USDMedian day 251,320 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026
Bio-Rad Laboratories, Inc. logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
NYSE:BIO · Home$358.90 USD-11.27 (-3.0%)182,296$364.34$369.44$353.31$370.17Close on Nov 20, 2026
NYSE:BIO.B$389.98 USD+10.48 (+2.8%)154$389.98$389.98$389.98$379.50Close on Nov 9, 2026
Frankfurt:BUWA€325.40 EUR-10.80 (-3.2%)—€330.80€330.80€323.20€336.20Close on Nov 20, 2026
Frankfurt:BUW€304.00 EUR0.00 (0.0%)—€304.00€304.00€304.00€304.00Close on Nov 20, 2026

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NYSE:BIO · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$358.90-11.27-3.0%$364.34$369.44$353.31182,296
$370.17+11.98+3.3%$358.00$370.65$358.00460,451
$358.19-2.07-0.6%$359.39$361.69$356.58202,626
$360.26-6.10-1.7%$363.83$365.61$358.64169,935
$366.36-4.12-1.1%$370.19$373.50$364.11255,113
$370.48-15.52-4.0%$382.88$389.98$369.40182,297
$386.00-0.48-0.1%$388.31$389.61$382.76212,180
$386.48-1.83-0.5%$386.92$390.44$381.77210,957
$388.31+6.74+1.8%$385.38$394.73$381.59547,366
$381.57+12.57+3.4%$364.45$384.62$363.59273,122
$369.00-10.99-2.9%$367.29$375.07$352.09433,887
$379.99+5.08+1.4%$380.05$382.00$371.85281,796
$374.91+8.75+2.4%$369.45$376.81$369.45214,401
$366.16-6.02-1.6%$374.79$377.90$361.27211,830
$372.18-12.22-3.2%$381.09$381.29$368.45183,084
$384.40-0.72-0.2%$389.15$390.00$379.24332,334
$385.12+4.13+1.1%$384.15$388.86$380.17251,320
$380.99+8.56+2.3%$376.25$381.87$369.41167,153
$372.43+2.48+0.7%$371.80$376.00$369.76179,098
$369.95+6.45+1.8%$356.98$371.31$352.46167,404
$363.50+3.00+0.8%$359.83$367.93$359.83228,223
$360.50+6.00+1.7%$350.21$362.42$347.29360,455
$354.50+1.68+0.5%$352.08$356.93$350.49212,450
$352.82-0.88-0.2%$355.30$356.34$350.61220,861
$353.70-11.12-3.0%$369.37$369.37$350.77207,700
$364.82+2.39+0.7%$364.90$368.54$359.88247,800
$362.43-1.30-0.4%$367.86$371.07$361.27297,400
$363.73-0.69-0.2%$369.00$369.43$358.43132,600
$364.42-1.74-0.5%$369.85$369.85$359.41181,100
$366.16+5.76+1.6%$364.32$368.67$361.32139,000
$360.40-7.52-2.0%$371.99$372.59$353.97312,000
$367.92-0.91-0.2%$373.16$374.60$363.98251,900
$368.83-10.99-2.9%$383.38$390.00$367.49162,538
$379.82+10.68+2.9%$368.07$381.78$363.96279,402
$369.14+13.57+3.8%$357.28$369.40$357.28223,600
$355.57-22.14-5.9%$373.87$379.67$353.30264,600
$377.71-1.84-0.5%$377.61$380.88$374.02228,600
$379.55+1.86+0.5%$377.73$381.56$374.79261,700
$377.69-3.31-0.9%$376.98$383.95$373.18272,600
$381.00-6.54-1.7%$384.14$387.00$376.43253,600
$387.54+8.66+2.3%$377.73$389.38$376.18374,200
$378.88-0.69-0.2%$379.27$382.85$374.77177,200
$379.57+2.24+0.6%$377.53$383.25$374.01374,700
$377.33+0.92+0.2%$381.58$381.58$373.47311,500
$376.41-6.00-1.6%$383.05$383.05$374.81324,347
$382.41+3.38+0.9%$384.23$385.71$377.69205,000
$379.03+1.03+0.3%$378.25$385.33$375.00262,400
$378.00+9.45+2.6%$366.33$380.91$366.28519,131
$368.55-0.77-0.2%$365.66$370.52$365.66292,990
$369.32+0.57+0.2%$370.45$373.71$368.69344,800
$368.75-8.22-2.2%$379.92$382.01$368.56334,400
$376.97-3.15-0.8%$380.00$380.06$373.34177,000
$380.12-5.99-1.6%$390.73$390.73$379.49138,800
$386.11-1.79-0.5%$380.84$386.78$376.20112,900
$387.90-0.61-0.2%$390.00$394.29$381.06148,000
$388.51+7.55+2.0%$380.62$389.83$380.23285,333
$380.96-5.16-1.3%$387.88$387.88$380.27256,110
$386.12-1.58-0.4%$393.85$394.02$382.13301,423
$387.70-2.24-0.6%$390.82$392.29$382.10207,000
$389.94+1.30+0.3%$389.03$396.23$386.69245,900
$388.64-1.70-0.4%$393.10$393.10$385.50221,700
$390.34+8.58+2.2%$384.00$390.83$377.80295,718
$381.76+1.73+0.5%$384.09$384.09$373.40300,154
$380.03+3.57+0.9%$385.80$385.92$373.47341,200
$376.46+12.20+3.3%$360.29$380.71$360.25337,500

Splits

5 splits since 1980 · NYSE:BIO · every price before a split is adjusted for it

DayRatioWhat
2-for-1Split
3-for-2Split
3-for-2Split
3-for-2Split
2-for-1Split
Ticker
Lang & Schwarz:862449
Asset type
Stock
Sector
Health care
Industry
Diagnostics & research services
Exchange
Lang & Schwarz
Currency
EUR

What changed lately

Latest news

All Bio-Rad Laboratories, Inc. news

Bio-Rad Laboratories, Inc. on 6ix

Sector
Health care
Industry
Diagnostics & research services
News releases
12 in the last 12 months · 26 in all · newest Nov 4, 2026 · oldest 2025
Calls
32 calls with a replay · 32 with a transcript · latest Nov 4, 2026
Decks
24 decks · latest Nov 4, 2026

Where Bio-Rad Laboratories, Inc. is listed

ListingExchangeCountryCurrency
NYSE:BIO · Home listingNYSEUnited StatesUSD
NYSE:BIO.BNYSEUnited StatesUSD
BOATS:BIOBOATSUnited StatesUSD
gettex:BUWAgettexGermanyEUR
LS Exchange:865406LS ExchangeGermanyEUR
Lang & Schwarz:865406Lang & SchwarzGermanyEUR
Tradegate:BUWATradegateGermanyEUR
BOATS:BIO.BBOATSUnited StatesUSD
Frankfurt:BUWAFrankfurtGermanyEUR
Stuttgart:BUWAStuttgartGermanyEUR
Dusseldorf:BUWADusseldorfGermanyEUR
Frankfurt:BUWFrankfurtGermanyEUR
Munich:BUWAMunichGermanyEUR
Lang & Schwarz:862449 · This pageLang & SchwarzGermanyEUR
LS Exchange:862449LS ExchangeGermanyEUR

Valuation

P/E 7.7× against a median of 38.4×: the lowest of 6 Diagnostics & research services companies shown. Statements: 4 quarters to Sep 30, 2026 · price Nov 20, 2026

Enterprise value
$7.38B USD
P/E
7.7×
EV/sales
2.8×
EV/EBITDA
71.0×
Price/book
1.0×
Gross margin
51.3%
Operating margin
−2.4%
Net margin
39.5%
Debt to equity
0.2×
Beta vs S&P 500
0.72

Diagnostics & research services: the 10 companies nearest in size, of 302 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
Bio-Rad Laboratories, Inc. · NYSE:BIOUS$7.84BUS$7.38B7.7×2.8×71.0×1.0×39.5%0.2×0.72
WuXi XDC Cayman, Inc. · HKEX:2268US$9.64BUS$8.87B43.5×10.0×33.5×5.7×24.9%0.1×n/a
Tempus AI, Inc. · NASDAQ:TEMUS$9.58BUS$8.99Bn/a6.0×n/a19.1×−12.5%0.0×2.51
Bruker Corporation · NASDAQ:BRKRUS$8.62BUS$10.22Bn/a2.9×64.4×3.7×−3.5%0.7×1.72
Pharmaron Beijing Co., Ltd. Class A · SZSE:300759US$8.52BUS$8.23B32.1×3.4×n/a3.4×11.1%0.1×n/a
GenScript Biotech Corporation · HKEX:1548US$8.08BUS$7.50Bn/a7.8×22.8×2.1×−55.5%0.1×n/a
Shenzhen New Industries Biomedical Engineering Co. Ltd. Class A · SZSE:300832US$7.51BUS$7.10B27.8×9.8×n/a5.3×37.2%0.0×n/a
Twist Bioscience Corporation · NASDAQ:TWSTUS$7.04BUS$6.46Bn/a14.1×n/a7.9×−28.3%0.0×2.77
Asymchem Laboratories (Tianjin) Co., Ltd. Class A · SZSE:002821US$6.83BUS$5.89B38.5×5.3×n/a2.6×15.9%0.0×n/a
Bachem Holding AG Class B · SIX:BANBUS$6.80BUS$6.99B38.4×8.4×29.7×4.0×21.4%0.1×n/a
10x Genomics, Inc. · NASDAQ:TXGUS$6.29BUS$5.79Bn/a9.4×n/a7.5×−10.8%0.1×2.34
Median of the othersUS$7.79BUS$7.30B38.4×8.1×31.6×4.6×3.8%0.1×2.42

Forecasts

1 buy · 1 hold · 1 sell · Analysts' consensus from EODHD, read Nov 22, 2026. Not 6ix's view and not investment advice.

Price target
356.67 USD · Analysts' mean
EPS, year to Dec 2026
9.61 · 3 analysts
Revenue, year to Dec 2026
2.57B · 3 analysts

Team and board

OfficerRole
Norman SchwartzCEO
Anna GralinskaCorporate Communications
Edward ChungInvestor Relations
Ruben ArguetaInvestor Relations

Events

Calls

CallWhenStatus
Bio-Rad Laboratories (NYSE:BIO) Q3 2026 Earnings CallWed, Nov 04, 2026 · 5:00 PM ETReplay
Bio-Rad Laboratories (NYSE:BIO) Q2 2026 Earnings CallTue, Aug 04, 2026 · 5:00 PM ETReplay
Bio-Rad Laboratories (NYSE:BIO) Q1 2026 Earnings CallThu, Apr 30, 2026 · 5:00 PM ETReplay
Bio-Rad Laboratories (NYSE:BIO) Q4 2025 Earnings CallThu, Feb 12, 2026 · 5:00 PM ETReplay
Bio-Rad Laboratories (NYSE:BIO) Q3 2025 Earnings CallWed, Oct 29, 2025 · 5:00 PM ETReplay
Bio-Rad Laboratories (NYSE:BIO) Q2 2025 Earnings CallThu, Jul 31, 2025 · 5:00 PM ETReplay
Bio-Rad Laboratories (NYSE:BIO) Q1 2025 Earnings CallThu, May 01, 2025 · 5:30 PM ETReplay
Bio-Rad Laboratories (NYSE:BIO) Q4 2024 Earnings CallThu, Feb 13, 2025 · 5:00 PM ETReplay
Bio-Rad Laboratories (NYSE:BIO) Q3 2024 Earnings CallWed, Oct 30, 2024 · 5:00 PM ETReplay
Bio-Rad Laboratories (NYSE:BIO) Q2 2024 Earnings CallThu, Aug 01, 2024 · 5:00 PM ETReplay
All 32 calls
CallWhenStatus
Bio-Rad Laboratories (NYSE:BIO) Q1 2024 Earnings CallTue, May 07, 2024 · 5:00 PM ETReplay
Bio-Rad Laboratories (NYSE:BIO) Q4 2023 Earnings CallThu, Feb 15, 2024 · 5:00 PM ETReplay
Bio-Rad Laboratories (NYSE:BIO) Q3 2023 Earnings CallThu, Oct 26, 2023 · 5:00 PM ETReplay
Bio-Rad Laboratories (NYSE:BIO) Q2 2023 Earnings CallThu, Aug 03, 2023 · 5:00 PM ETReplay
Bio-Rad Laboratories (NYSE:BIO) Q1 2023 Earnings CallThu, May 04, 2023 · 5:00 PM ETReplay
Bio-Rad Laboratories (NYSE:BIO) Q4 2022 Earnings CallWed, Feb 15, 2023 · 4:30 PM ETReplay
Bio-Rad Laboratories (NYSE:BIO) Q3 2022 Earnings CallThu, Oct 27, 2022 · 5:00 PM ETReplay
Bio-Rad Laboratories (NYSE:BIO) Q2 2022 Earnings CallThu, Jul 28, 2022 · 6:00 PM ETReplay
Bio-Rad Laboratories (NYSE:BIO) Q1 2022 Earnings CallThu, Apr 28, 2022 · 6:00 PM ETReplay
Bio-Rad Laboratories (NYSE:BIO) Q4 2021 Earnings CallThu, Feb 10, 2022 · 6:00 PM ETReplay
Bio-Rad Laboratories (NYSE:BIO) Q3 2021 Earnings CallThu, Oct 28, 2021 · 5:00 PM ETReplay
Bio-Rad Laboratories (NYSE:BIO) Q2 2021 Earnings CallThu, Jul 29, 2021 · 6:00 PM ETReplay
Bio-Rad Laboratories (NYSE:BIO) Q1 2021 Earnings CallThu, Apr 29, 2021 · 6:00 PM ETReplay
Bio-Rad Laboratories (NYSE:BIO) Q4 2020 Earnings CallThu, Feb 11, 2021 · 6:00 PM ETReplay
Bio-Rad Laboratories (NYSE:BIO) Q3 2020 Earnings CallThu, Oct 29, 2020 · 6:00 PM ETReplay
Bio-Rad Laboratories (NYSE:BIO) Q2 2020 Earnings CallThu, Jul 30, 2020 · 6:00 PM ETReplay
Bio-Rad Laboratories (NYSE:BIO) Q1 2020 Earnings CallWed, May 06, 2020 · 5:00 PM ETReplay
Bio-Rad Laboratories (NYSE:BIO) Q4 2019 Earnings CallThu, Feb 13, 2020 · 5:00 PM ETReplay
Bio-Rad Laboratories (NYSE:BIO) Q3 2019 Earnings CallThu, Oct 31, 2019 · 5:00 PM ETReplay
Bio-Rad Laboratories (NYSE:BIO) Q2 2019 Earnings CallThu, Aug 01, 2019 · 5:00 PM ETReplay
Bio-Rad Laboratories (NYSE:BIO) Q1 2019 Earnings CallWed, May 08, 2019 · 5:00 PM ETReplay
Bio-Rad Laboratories (NYSE:BIO) Q4 2018 Earnings CallThu, Feb 28, 2019 · 5:00 PM ETReplay

Results days

QuarterResultsShare move
Q3 2026Nov 4, 2026 · After close−2.9%
Q2 2026Aug 4, 2026 · After close+4.5%
Q1 2026Apr 30, 2026 · After close−8.4%
Q4 2025Feb 12, 2026 · After close−12.3%
Q3 2025Oct 29, 2025 · After close−4.7%
Q2 2025Jul 31, 2025 · After close+17.6%
Q1 2025May 1, 2025 · After close−1.7%
Q4 2024Feb 13, 2025 · After close−9.5%
Q3 2024Oct 30, 2024 · After close+8.3%
Q2 2024Aug 1, 2024 · After close−1.6%
All 20 quarters
QuarterResultsShare move
Q1 2024May 7, 2024 · After close−4.2%
Q4 2023Feb 15, 2024 · After close+3.6%
Q3 2023Oct 26, 2023 · After close−7.2%
Q2 2023Aug 3, 2023 · After close−0.5%
Q1 2023May 4, 2023 · After close−16.7%
Q4 2022Feb 16, 2023 · After close+6.0%
Q3 2022Oct 27, 2022 · After close−8.0%
Q2 2022Jul 28, 2022 · After close+0.6%
Q1 2022Apr 28, 2022 · After close−0.2%
Q4 2021Feb 10, 2022 · After close+0.7%

Open Events

Decks

DeckKindSlidesDate
Q3 2026 Earnings PresentationEarnings16 slidesNov 4, 2026
Q2 2026 Earnings PresentationEarnings18 slidesAug 4, 2026
Q1 2026 Earnings PresentationEarnings18 slidesApr 30, 2026
Q4 2025 Earnings PresentationEarnings26 slidesFeb 12, 2026
Q3 2025 Earnings PresentationEarnings17 slidesOct 29, 2025
Bio-Rad's Droplet Digital PCR Webinar (August 2025)Conference18 slidesAug 26, 2025
Q2 2025 Earnings PresentationEarnings15 slidesJul 31, 2025
Investor Presentation (February 2024)Investor deck96 slidesFebruary 2024
Jefferies Healthcare Conference 2023Conference18 slidesJun 8, 2023
J.P. Morgan Healthcare Conference 2023Conference26 slidesJan 10, 2023
All 24 decks
DeckKindSlidesDate
J.P. Morgan 41st Annual Healthcare Conference 2023Conference26 slidesJan 10, 2023
Technical Presentation (2023)Technical80 slides2023
Technical Presentation (2022)Technical129 slidesDec 14, 2022
Investor Day (February 2022)Investor day102 slidesFeb 25, 2022
Investor Day (December 2020)Investor day12 slidesDec 10, 2020
Technical Presentation (2020)Technical47 slides2020
Technical Presentation (2020)Technical44 slides2020
Jefferies 2019 Healthcare ConferenceConference26 slides2019
Barclays Global Healthcare Conference 2018Conference23 slides2018
Investor Presentation (September 2016)Investor deck19 slidesSep 9, 2016
Investor Presentation (September 2015)Investor deck56 slidesSeptember 2015
Investor Presentation (March 2013)Investor deck20 slidesMarch 2013
Technical Presentation (2007)Technical22 slides2007
第二届国际分析技术博览会 (Analytica China 2004), ShanghaiConference36 slidesSeptember 2004

Open Decks

Financials

Annual, in USD

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue2.58B2.57B2.67B2.80B2.92B2.55B2.31B2.29B2.16B2.07B
Cost of revenue1.24B1.19B1.24B1.23B1.28B1.11B1.05B1.07B972.5M929.7M
Gross profit1.34B1.38B1.43B1.57B1.64B1.44B1.26B1.22B1.19B1.14B
Research and development275.6M295.9M247.4M256.9M260.6M217.8M202.7M199.2M250.2M205.7M
Selling, general and administrative844.3M814.0M841.7M827.8M877.1M798.8M824.6M834.8M806.8M814.7M
Operating income47.2M269.0M337.8M482.6M500.3M421.3M229.7M-103.3M119.3M55.7M
Depreciation and amortization165.4M151.6M145.9M137.3M137.6M138.6M134.2M138.1M148.7M142.9M
EBITDA212.6M420.6M483.7M619.9M637.9M559.9M363.9M34.8M267.9M198.6M
Interest expense49.0M48.9M49.4M38.1M1.55M21.9M23.4M24.0M23.0M23.4M
Income before tax995.5M-2.34B-850.1M-4.70B5.45B4.92B2.26B512.7M97.8M41.6M
Income tax235.6M-498.3M-212.8M-1.08B1.19B1.10B502.4M147.0M-24.4M15.6M
Net income759.9M-1.84B-637.3M-3.63B4.25B3.81B1.76B365.6M122.2M26.0M
Earnings per share, basic27.87-65.36-21.82-121.79142.61128.1358.9312.254.120.88
Earnings per share, diluted27.85-65.36-21.82-121.79140.83126.4758.2712.104.070.88

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents529.8M488.1M403.8M434.2M470.8M662.2M660.7M431.5M383.8M456.3M
Short-term investments1.01B1.18B1.20B1.36B399.1M328.9M454.0M413.3M371.2M383.2M
Receivables460.6M452.5M489.0M494.6M423.5M419.4M392.7M392.4M464.8M372.3M
Inventory740.7M760.0M780.5M719.3M572.2M622.3M554.0M583.8M594.8M525.0M
Current assets2.91B3.03B3.05B3.16B1.99B2.14B2.18B2.02B1.98B1.84B
Property, plant and equipment539.9M528.1M529.0M498.6M511.6M491.4M499.3M508.7M493.5M488.6M
Goodwill579.8M410.5M413.6M406.5M347.3M291.9M264.1M219.8M506.1M477.1M
Total assets10.6B9.36B12.3B13.5B17.8B13.0B8.01B5.61B4.27B3.85B
Accounts payable129.0M122.3M144.6M135.0M141.9M139.5M107.0M122.5M135.2M133.1M
Current liabilities517.0M467.8M522.8M568.7M680.9M631.5M905.5M450.8M502.7M471.3M
Long-term debt1.20B1.20B1.20B1.20B10.5M12.3M13.6M438.9M434.6M434.2M
Total debt1.20B1.20B1.21B1.20B10.5M12.3M13.6M438.9M435.0M434.5M
Total liabilities3.12B2.79B3.56B3.89B4.11B3.09B2.25B1.59B1.34B1.27B
Shareholders' equity7.45B6.57B8.74B9.62B13.7B9.89B5.76B4.02B2.93B2.58B
Shares outstanding27.3M28.2M29.2M29.8M30.2M30.2M30.2M30.2M30.0M29.6M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations532.2M455.2M374.9M194.4M669.5M585.0M457.9M285.5M104.1M216.1M
Capital spending-157.6M-165.6M-156.7M-112.8M-133.7M-108.6M-98.5M-129.8M-111.3M-141.4M
Free cash flow374.6M289.6M218.2M81.6M535.7M476.4M359.4M155.7M-7.20M74.6M
Cash from investing-189.7M-160.2M20.2M-1.21B-797.4M-69.9M-208.9M-187.0M-175.6M-213.9M
Cash from financing-283.2M-218.8M-425.6M973.6M-55.4M-523.0M-22.8M-48.7M341.0K9.02M
Dividends paid-100.1B-68.2B-35.3B-20.2M-3.83B-4.37M
Share buybacks-295.5M-203.6M-428.7M-215.7M-50.0M-100.0M-28.0M-48.9M-2.92M0
Change in cash42.4M85.4M-30.1M-36.6M-196.0M4.46M228.5M49.2M-72.4M-1.28M

Open Financials

Filings

FilingDateTypeFiled with
4 · Change in ownershipNov 12, 2026Insider tradeSEC
4 · Change in ownershipNov 12, 2026Insider tradeSEC
4 · Change in ownershipNov 12, 2026Insider tradeSEC
144 · Notice of proposed saleNov 10, 2026Other filingsSEC
144 · Notice of proposed saleNov 9, 2026Other filingsSEC
144 · Notice of proposed saleNov 9, 2026Other filingsSEC
10-Q · Quarterly reportNov 4, 2026Quarterly reportSEC
8-K · Current reportNov 4, 2026ResultsSEC
4 · Change in ownershipOct 27, 2026Insider tradeSEC
4 · Change in ownershipOct 22, 2026Insider tradeSEC
Show 200 filings
FilingDateTypeFiled with
4 · Change in ownershipSep 9, 2026Insider tradeSEC
4 · Change in ownershipSep 9, 2026Insider tradeSEC
4 · Change in ownershipSep 9, 2026Insider tradeSEC
4 · Change in ownershipSep 9, 2026Insider tradeSEC
4 · Change in ownershipSep 9, 2026Insider tradeSEC
4 · Change in ownershipSep 9, 2026Insider tradeSEC
4 · Change in ownershipSep 9, 2026Insider tradeSEC
4 · Change in ownershipSep 9, 2026Insider tradeSEC
4 · Change in ownershipSep 9, 2026Insider tradeSEC
4 · Change in ownershipSep 3, 2026Insider tradeSEC
4 · Change in ownershipSep 3, 2026Insider tradeSEC
4 · Change in ownershipSep 3, 2026Insider tradeSEC
10-Q · Quarterly reportAug 4, 2026Quarterly reportSEC
8-K · Current reportAug 4, 2026ResultsSEC
4 · Change in ownershipJul 28, 2026Insider tradeSEC
144 · Notice of proposed saleMay 28, 2026Other filingsSEC
SD · Specialized disclosureMay 13, 2026ESG reportSEC
4 · Change in ownershipMay 13, 2026Insider tradeSEC
144 · Notice of proposed saleMay 11, 2026Other filingsSEC
S-8 · Registration statement for employee plansApr 30, 2026Offer documentSEC
10-Q · Quarterly reportApr 30, 2026Quarterly reportSEC
8-K · Current reportApr 30, 2026ResultsSEC
4 · Change in ownershipApr 28, 2026Insider tradeSEC
4 · Change in ownershipApr 28, 2026Insider tradeSEC
8-K · Current reportApr 24, 2026Management or board changeSEC
4 · Change in ownershipApr 23, 2026Insider tradeSEC
4 · Change in ownershipApr 23, 2026Insider tradeSEC
4 · Change in ownershipApr 23, 2026Insider tradeSEC
4 · Change in ownershipApr 23, 2026Insider tradeSEC
SCHEDULE 13G/A · Big-stake notice, amendedMar 26, 2026Big-stake noticeSEC
ARS · Annual report to shareholdersMar 25, 2026Annual reportSEC
DEF 14A · Proxy statementMar 25, 2026Meeting noticeSEC
8-K · Current reportFeb 19, 2026Current reportSEC
10-K · Annual reportFeb 12, 2026Annual reportSEC
8-K · Current reportFeb 12, 2026ResultsSEC
144 · Notice of proposed saleDec 2, 2025Other filingsSEC
144 · Notice of proposed saleNov 18, 2025Other filingsSEC
4 · Change in ownershipNov 10, 2025Insider tradeSEC
144 · Notice of proposed saleNov 6, 2025Other filingsSEC
SCHEDULE 13D/A · Big-stake notice, amendedOct 30, 2025Big-stake noticeSEC
SCHEDULE 13D/A · Big-stake notice, amendedOct 30, 2025Big-stake noticeSEC
10-Q · Quarterly reportOct 29, 2025Quarterly reportSEC
8-K · Current reportOct 29, 2025ResultsSEC
SCHEDULE 13D/A · Big-stake notice, amendedOct 28, 2025Big-stake noticeSEC
SCHEDULE 13D/A · Big-stake notice, amendedOct 28, 2025Big-stake noticeSEC
4 · Change in ownershipOct 28, 2025Insider tradeSEC
4 · Change in ownershipOct 21, 2025Insider tradeSEC
SCHEDULE 13G/A · Big-stake notice, amendedOct 17, 2025Big-stake noticeSEC
8-K · Current reportSep 30, 2025Current reportSEC
4 · Change in ownershipSep 9, 2025Insider tradeSEC
4 · Change in ownershipSep 9, 2025Insider tradeSEC
4 · Change in ownershipSep 9, 2025Insider tradeSEC
4 · Change in ownershipSep 9, 2025Insider tradeSEC
4 · Change in ownershipSep 9, 2025Insider tradeSEC
4 · Change in ownershipSep 9, 2025Insider tradeSEC
4 · Change in ownershipSep 9, 2025Insider tradeSEC
4 · Change in ownershipSep 9, 2025Insider tradeSEC
4 · Change in ownershipSep 9, 2025Insider tradeSEC
4 · Change in ownershipSep 9, 2025Insider tradeSEC
4 · Change in ownershipSep 3, 2025Insider tradeSEC
4 · Change in ownershipSep 3, 2025Insider tradeSEC
4 · Change in ownershipSep 3, 2025Insider tradeSEC
4 · Change in ownershipSep 3, 2025Insider tradeSEC
8-K · Current reportAug 26, 2025Current reportSEC
3 · Initial statement of ownershipAug 14, 2025Insider tradeSEC
SCHEDULE 13G/A · Big-stake notice, amendedAug 6, 2025Big-stake noticeSEC
144 · Notice of proposed saleAug 5, 2025Other filingsSEC
10-Q · Quarterly reportJul 31, 2025Quarterly reportSEC
8-K · Current reportJul 31, 2025ResultsSEC
4 · Change in ownershipJul 29, 2025Insider tradeSEC
8-K · Current reportJul 28, 2025Management or board changeSEC
SCHEDULE 13D/A · Big-stake notice, amendedJul 18, 2025Big-stake noticeSEC
8-K · Current reportJun 30, 2025Current reportSEC
SD · Specialized disclosureMay 20, 2025ESG reportSEC
SCHEDULE 13G/A · Big-stake notice, amendedMay 5, 2025Big-stake noticeSEC
SCHEDULE 13G · Big-stake noticeMay 5, 2025Big-stake noticeSEC
10-Q · Quarterly reportMay 1, 2025Quarterly reportSEC
8-K · Current reportMay 1, 2025ResultsSEC
4 · Change in ownershipApr 25, 2025Insider tradeSEC
4 · Change in ownershipApr 25, 2025Insider tradeSEC
8-K · Current reportApr 25, 2025Meeting outcomeSEC
4 · Change in ownershipApr 24, 2025Insider tradeSEC
4 · Change in ownershipApr 24, 2025Insider tradeSEC
4 · Change in ownershipApr 24, 2025Insider tradeSEC
4 · Change in ownershipApr 24, 2025Insider tradeSEC
ARS · Annual report to shareholdersMar 26, 2025Annual reportSEC
DEF 14A · Proxy statementMar 26, 2025Meeting noticeSEC
4 · Change in ownershipMar 18, 2025Insider tradeSEC
144 · Notice of proposed saleMar 13, 2025Other filingsSEC
144 · Notice of proposed saleMar 11, 2025Other filingsSEC
4 · Change in ownershipMar 5, 2025Insider tradeSEC
4 · Change in ownershipMar 5, 2025Insider tradeSEC
4 · Change in ownershipMar 5, 2025Insider tradeSEC
4 · Change in ownershipMar 5, 2025Insider tradeSEC
4 · Change in ownershipMar 5, 2025Insider tradeSEC
4 · Change in ownershipMar 5, 2025Insider tradeSEC
4 · Change in ownershipMar 5, 2025Insider tradeSEC
4 · Change in ownershipMar 5, 2025Insider tradeSEC
SCHEDULE 13G/A · Big-stake notice, amendedMar 4, 2025Big-stake noticeSEC
8-K · Current reportFeb 21, 2025Current reportSEC
10-K · Annual reportFeb 14, 2025Annual reportSEC
8-K · Current reportFeb 13, 2025ResultsSEC
SCHEDULE 13G/A · Big-stake notice, amendedDec 20, 2024Big-stake noticeSEC
SC 13G · Big-stake noticeNov 14, 2024Big-stake noticeSEC
SC 13G/A · Big-stake notice, amendedNov 12, 2024Big-stake noticeSEC
SC 13G/A · Big-stake notice, amendedNov 8, 2024Big-stake noticeSEC
144 · Notice of proposed saleNov 6, 2024Other filingsSEC
SC 13G/A · Big-stake notice, amendedNov 4, 2024Big-stake noticeSEC
10-Q · Quarterly reportOct 31, 2024Quarterly reportSEC
8-K · Current reportOct 30, 2024ResultsSEC
4 · Change in ownershipOct 25, 2024Insider tradeSEC
SC 13G/A · Big-stake notice, amendedOct 24, 2024Big-stake noticeSEC
4 · Change in ownershipOct 22, 2024Insider tradeSEC
SC 13G/A · Big-stake notice, amendedOct 22, 2024Big-stake noticeSEC
SC 13G/A · Big-stake notice, amendedOct 10, 2024Big-stake noticeSEC
SC 13G · Big-stake noticeOct 10, 2024Big-stake noticeSEC
3 · Initial statement of ownershipSep 17, 2024Insider tradeSEC
144 · Notice of proposed saleSep 12, 2024Other filingsSEC
4 · Change in ownershipSep 10, 2024Insider tradeSEC
4 · Change in ownershipSep 10, 2024Insider tradeSEC
4 · Change in ownershipSep 10, 2024Insider tradeSEC
4 · Change in ownershipSep 10, 2024Insider tradeSEC
4 · Change in ownershipSep 10, 2024Insider tradeSEC
4 · Change in ownershipSep 10, 2024Insider tradeSEC
4 · Change in ownershipSep 10, 2024Insider tradeSEC
4 · Change in ownershipSep 10, 2024Insider tradeSEC
4 · Change in ownershipSep 10, 2024Insider tradeSEC
4 · Change in ownershipSep 10, 2024Insider tradeSEC
4 · Change in ownershipSep 10, 2024Insider tradeSEC
4 · Change in ownershipSep 10, 2024Insider tradeSEC
4 · Change in ownershipSep 10, 2024Insider tradeSEC
4 · Change in ownershipSep 10, 2024Insider tradeSEC
8-K · Current reportSep 9, 2024Current reportSEC
144 · Notice of proposed saleSep 6, 2024Other filingsSEC
4 · Change in ownershipSep 5, 2024Insider tradeSEC
4 · Change in ownershipSep 4, 2024Insider tradeSEC
4 · Change in ownershipSep 4, 2024Insider tradeSEC
4 · Change in ownershipSep 4, 2024Insider tradeSEC
4 · Change in ownershipSep 4, 2024Insider tradeSEC
4 · Change in ownershipSep 4, 2024Insider tradeSEC
144 · Notice of proposed saleSep 4, 2024Other filingsSEC
4 · Change in ownershipAug 28, 2024Insider tradeSEC
4 · Change in ownershipAug 28, 2024Insider tradeSEC
4 · Change in ownershipAug 28, 2024Insider tradeSEC
4 · Change in ownershipAug 28, 2024Insider tradeSEC
144 · Notice of proposed saleAug 27, 2024Other filingsSEC
8-K · Current reportAug 20, 2024Management or board changeSEC
10-Q · Quarterly reportAug 2, 2024Quarterly reportSEC
8-K · Current reportAug 1, 2024ResultsSEC
4 · Change in ownershipJul 29, 2024Insider tradeSEC
3 · Initial statement of ownershipJun 17, 2024Insider tradeSEC
4 · Change in ownershipJun 14, 2024Insider tradeSEC
144 · Notice of proposed saleJun 13, 2024Other filingsSEC
SD · Specialized disclosureMay 9, 2024ESG reportSEC
S-8 · Registration statement for employee plansMay 8, 2024Offer documentSEC
10-Q · Quarterly reportMay 8, 2024Quarterly reportSEC
3 · Initial statement of ownershipMay 8, 2024Insider tradeSEC
8-K · Current reportMay 7, 2024ResultsSEC
4 · Change in ownershipMay 1, 2024Insider tradeSEC
4 · Change in ownershipApr 30, 2024Insider tradeSEC
4 · Change in ownershipApr 29, 2024Insider tradeSEC
4 · Change in ownershipApr 29, 2024Insider tradeSEC
3 · Initial statement of ownershipApr 29, 2024Insider tradeSEC
8-K · Current reportApr 26, 2024Management or board changeSEC
SC 13G · Big-stake noticeApr 22, 2024Big-stake noticeSEC
3 · Initial statement of ownershipApr 17, 2024Insider tradeSEC
8-K · Current reportApr 10, 2024Management or board changeSEC
DEF 14A · Proxy statementMar 27, 2024Meeting noticeSEC
ARS · Annual report to shareholdersMar 27, 2024Annual reportSEC
8-K · Current reportMar 20, 2024Management or board changeSEC
4 · Change in ownershipMar 12, 2024Insider tradeSEC
4 · Change in ownershipMar 12, 2024Insider tradeSEC
4 · Change in ownershipMar 12, 2024Insider tradeSEC
4 · Change in ownershipMar 12, 2024Insider tradeSEC
4 · Change in ownershipMar 12, 2024Insider tradeSEC
4 · Change in ownershipMar 12, 2024Insider tradeSEC
4 · Change in ownershipMar 12, 2024Insider tradeSEC
SC 13G/A · Big-stake notice, amendedMar 11, 2024Big-stake noticeSEC
4 · Change in ownershipFeb 29, 2024Insider tradeSEC
4 · Change in ownershipFeb 28, 2024Insider tradeSEC
144 · Notice of proposed saleFeb 28, 2024Other filingsSEC
144 · Notice of proposed saleFeb 27, 2024Other filingsSEC
144 · Notice of proposed saleFeb 27, 2024Other filingsSEC
8-K · Current reportFeb 21, 2024Current reportSEC
10-K · Annual reportFeb 16, 2024Annual reportSEC
8-K · Current reportFeb 15, 2024ResultsSEC
8-K · Current reportFeb 14, 2024Material contractSEC
SC 13G/A · Big-stake notice, amendedFeb 13, 2024Big-stake noticeSEC
SC 13G/A · Big-stake notice, amendedJan 29, 2024Big-stake noticeSEC
4 · Change in ownershipDec 19, 2023Insider tradeSEC

This page holds 200 of 1,002 filings. Open Filings

Open Filings · All of its filings on SEC EDGAR

Cap table

Built by 6ix from Bio-Rad Laboratories, Inc.’s releases

Common shares
21,832,130
Fully diluted
21,832,130

Fully diluted

LineShares
Common shares21,832,130

Share count over time

CountShares
Nov 22, 202621,832,130

Open Cap table

Shareholders

Institutions

HolderSharesOf the companyValueAs of
First Eagle Investment Management, LLC2.46M11.2%US$927MSep 30, 2026
Vanguard1.79M8.2%US$676MSep 30, 2026
BlackRock1.74M8.0%US$657MSep 30, 2026
Capital Group956K4.4%US$361MSep 30, 2026
Dimensional886K4.1%US$335MSep 30, 2026
UBS792K3.6%US$299MSep 30, 2026
Ariel Investments, LLC789K3.6%US$298MSep 30, 2026
State Street575K2.6%US$217MSep 30, 2026
Earnest Partners LLC568K2.6%US$214MSep 30, 2026
Bank of America439K2.0%US$166MSep 30, 2026
Show 50 holders
HolderSharesOf the companyValueAs of
Neuberger Berman Group LLC396K1.8%US$150MSep 30, 2026
Geode Capital343K1.6%US$129MSep 30, 2026
Barclays322K1.5%US$122MSep 30, 2026
Morgan Stanley308K1.4%US$116MSep 30, 2026
Sei Investments Co284K1.3%US$107MSep 30, 2026
First Pacific Advisors, LP269K1.2%US$102MSep 30, 2026
Deerfield Management Company, L.P.226K1.0%US$85.4MSep 30, 2026
Fidelity220K1.0%US$83.1MSep 30, 2026
Northern Trust213K0.98%US$80.6MSep 30, 2026
Schwab204K0.93%US$77.1MSep 30, 2026
Wellington192K0.88%US$72.7MSep 30, 2026
Franklin Templeton192K0.88%US$72.9MSep 30, 2026
Victory Capital188K0.86%US$71MSep 30, 2026
AQR Capital Management LLC172K0.79%US$65.1MSep 30, 2026
Gotham Asset Management, LLC172K0.79%US$65.1MSep 30, 2026
GW&K Investment Management, LLC164K0.75%US$61.9MSep 30, 2026
Assenagon Asset Management S.A.148K0.68%US$55.7MSep 30, 2026
Mangrove Partners Im, LLC127K0.58%US$48MSep 30, 2026
Acadian Asset Management LLC126K0.58%US$47.6MSep 30, 2026
Fisher Asset Management, LLC115K0.53%US$43.3MSep 30, 2026
BNY115K0.53%US$43.3MSep 30, 2026
Boston Trust Walden Corp106K0.48%US$39.9MSep 30, 2026
DME Capital Management, LP104K0.48%US$39.3MSep 30, 2026
Envestnet Asset Management Inc103K0.47%US$39.1MSep 30, 2026
D. E. Shaw & Co., Inc.96,7190.44%US$36.5MSep 30, 2026
Hosking Partners LLP95,4720.44%US$36.1MSep 30, 2026
Millennium95,3950.44%US$36MSep 30, 2026
Natixis Advisors, LLC89,2160.41%US$33.7MSep 30, 2026
Exchange Traded Concepts, LLC87,6910.40%US$33.1MSep 30, 2026
Manufacturers Life Insurance Company, The86,8480.40%US$32.8MSep 30, 2026
Jones Financial Companies Lllp85,2440.39%US$32.5MSep 30, 2026
JNE Partners LLP84,8170.39%US$32MSep 30, 2026
Nomura75,0400.34%US$28.3MSep 30, 2026
Marshall Wace, LLP67,9940.31%US$25.7MSep 30, 2026
Arrowstreet Capital, Limited Partnership66,5780.30%US$25.1MSep 30, 2026
National Bank Of Canada65,0000.30%US$24.6MSep 30, 2026
Portolan Capital Management, LLC55,7970.26%US$21.1MSep 30, 2026
Arnhold LLC55,5680.25%US$21MSep 30, 2026
Tikvah Management LLC53,9040.25%US$20.4MSep 30, 2026
Wells Fargo50,7420.23%US$19.2MSep 30, 2026

This page holds 50 of 410 holders. Open Shareholders

Funds

HolderSharesOf the companyValueAs of
First Eagle Global Fund1.88M8.6%US$611MJul 31, 2026
SMALLCAP World Fund Inc882K4.0%US$259MJun 30, 2026
iShares Core S&P Mid-Cap ETF617K2.8%US$181MJun 30, 2026
Vanguard Total Stock Market Index Fund585K2.7%US$172MJun 30, 2026
Vanguard Small-Cap Index Fund423K1.9%US$124MJun 30, 2026
Ariel Fund349K1.6%US$103MJun 30, 2026
U.S. Small Cap Value Portfolio291K1.3%US$94.8MJul 31, 2026
MFS Mid Cap Growth Fund277K1.3%US$86.6MMay 31, 2026
Vanguard Small-Cap Value Index Fund268K1.2%US$78.7MJun 30, 2026
FPA Crescent Fund244K1.1%US$71.8MJun 30, 2026
Show 50 holders
HolderSharesOf the companyValueAs of
Vanguard Extended Market Index Fund207K0.95%US$60.7MJun 30, 2026
Fidelity Value Fund130K0.60%US$42.4MJul 31, 2026
Dimensional US Small Cap Value ETF119K0.55%US$38.8MJul 31, 2026
Fidelity Extended Market Index Fund93,6570.43%US$29.3MMay 31, 2026
State Street(R) SPDR(R) Portfolio S&P 400(TM) Mid Cap ETF91,1820.42%US$26.8MJun 30, 2026
Ariel Appreciation Fund76,3000.35%US$22.4MJun 30, 2026
Victory Sycamore Small Company Opportunity Fund75,0000.34%US$22MJun 30, 2026
iShares Russell Mid-Cap ETF74,5380.34%US$21.9MJun 30, 2026
U.S. Small Cap Portfolio74,1510.34%US$24.1MJul 31, 2026
Dimensional U.S. Small Cap ETF71,5410.33%US$23.3MJul 31, 2026
Fidelity Mid Cap Index Fund68,7730.32%US$22.4MJul 31, 2026
Small Cap Core Fund66,9230.31%US$21.8MJul 31, 2026
First Eagle Global Equity ETF65,0040.30%US$20.3MMay 31, 2026
Strategic Advisers U.S. Total Stock Fund61,9880.28%US$19.4MMay 31, 2026
iShares S&P Mid-Cap 400 Growth ETF59,1850.27%US$17.4MJun 30, 2026
Schwab Fundamental U.S. Small Company ETF59,1750.27%US$18.5MMay 31, 2026
PIMCO RAE US Small Fund56,7550.26%US$16.7MJun 30, 2026
First Eagle U.S. Fund56,3290.26%US$18.3MJul 31, 2026
Vanguard Health Care Index Fund55,9860.26%US$17.5MMay 31, 2026
Dimensional U.S. Core Equity 2 ETF55,8790.26%US$18.2MJul 31, 2026
Dimensional U.S. Targeted Value ETF50,4030.23%US$16.4MJul 31, 2026
Schwab U.S. Mid-Cap ETF49,1650.23%US$15.4MMay 31, 2026
Allspring Opportunity Fund46,1940.21%US$13.6MJun 30, 2026
Putnam Core Equity Fund44,8070.21%US$14.6MJul 31, 2026
Column Mid Cap Select Fund44,0520.20%US$13.8MMay 31, 2026
Boston Trust Walden Small Cap Fund41,5940.19%US$12.2MJun 30, 2026
iShares S&P Mid-Cap 400 Value ETF40,6890.19%US$11.9MJun 30, 2026
iShares Russell 1000 Value ETF40,6080.19%US$11.9MJun 30, 2026
Franklin Mutual U.S. Mid Cap Value Fund36,8200.17%US$12MJul 31, 2026
Fidelity Total Market Index Fund34,6800.16%US$10.8MMay 31, 2026
U.S. Targeted Value Portfolio31,6820.15%US$10.3MJul 31, 2026
U.S. Core Equity 1 Portfolio31,2330.14%US$10.2MJul 31, 2026
Vanguard S&P Mid-Cap 400 Index Fund28,9740.13%US$9.05MMay 31, 2026
Fidelity Series Total Market Index Fund27,9230.13%US$8.73MMay 31, 2026
iShares Russell Mid-Cap Value ETF27,9180.13%US$8.2MJun 30, 2026
AQR Style Premia Alternative Fund27,7620.13%US$8.15MJun 30, 2026
U.S. Core Equity 2 Portfolio27,3520.13%US$8.9MJul 31, 2026
AMG GW&K Small/Mid Cap Core Fund24,9050.11%US$7.31MJun 30, 2026
Transamerica Mid Cap Value Opportunities24,3080.11%US$7.91MJul 31, 2026
SMALLCAP World Fund24,2210.11%US$7.11MJun 30, 2026

This page holds 50 of 354 holders. Open Shareholders

Big stakes

StakeStakeSharesDateFiling
Norman D. Schwartz14.60%3.23MSep 25, 2025Schedule 13D
Alice N. Schwartz12.30%2.73MMay 1, 2025Schedule 13D
First Eagle Investment Management, LLC11.40%2.53MJun 30, 2025Schedule 13G
BlackRock, Inc.7.40%1.62MSep 30, 2025Schedule 13G

Open Shareholders

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Ted W Love
Other companies: Lisata Therapeutics, Inc. (Director · Since at least Sep 17, 2026); Jazz Pharmaceuticals plc (Director · Since at least Dec 1, 2025); Gilead Sciences, Inc. (Director · Since at least Feb 1, 2024); Structure Therapeutics, Inc. (Director · Since at least Aug 3, 2023); Royalty Pharma plc (Director · Since at least Jul 30, 2020); Seagen Inc (Director · Aug 16, 2020 – Dec 14, 2023 · Past); Portola Pharmaceuticals Inc (Director · Sep 18, 2019 – Jul 2, 2020 · Past); Global Blood Therapeutics Inc (President and CEO, Director · Aug 11, 2015 – Oct 5, 2022 · Past); Cascadian Therapeutics Inc (Director · Sep 5, 2013 – Mar 9, 2018 · Past); Savara, Inc. (Director · Sep 5, 2012 – Jun 19, 2013 · Past); Humanigen Inc (Director · Aug 10, 2012 – Jul 10, 2015 · Past); Amicus Therapeutics Inc (Director · Jun 13, 2012 – Jun 4, 2020 · Past); Onyx Pharmaceuticals Inc (EVP, R&D and Tech. Operations · Feb 1, 2010 – Jul 25, 2012 · Past); Affymax Inc (Director · Dec 14, 2006 – Jun 13, 2012 · Past); Santarus Inc (Director · Jun 7, 2006 – Jan 2, 2014 · Past); Oruka Therapeutics, Inc. (Director · Mar 7, 2006 – Feb 5, 2010 · Past)
Director · Mar 24, 2010 – Mar 24, 2010 · Past
Ilan Daskal
Other companies: Viavi Solutions Inc. (Executive Vice President and Chief Financial Officer · Since at least Nov 7, 2023); PishPosh, Inc. (Director · Mar 18, 2020 – Jul 21, 2022 · Past); SunEdison Inc (EVP & CFO Designee · Apr 1, 2016 – Apr 8, 2016 · Past); TerraForm Power Inc (Director · Mar 30, 2016 – Mar 30, 2016 · Past); Ixia (Director · Jun 26, 2015 – Apr 18, 2017 · Past); Cepheid (EVP, Chief Financial Officer · Apr 9, 2015 – Apr 9, 2015 · Past); International Rectifier Corp (Executive Vice President & CFO · Oct 6, 2011 – Jan 13, 2015 · Past)
EVP, Chief Financial Officer · Apr 6, 2019 – Sep 1, 2023 · Past
Gregory K Hinckley
Other companies: SI-BONE, Inc. (Director · Since at least Oct 16, 2018); Super Micro Computer, Inc. (Director · Feb 8, 2011 – Feb 10, 2015 · Past); Mentor Graphics Corp (President · Sep 15, 2010 – Mar 30, 2017 · Past); Intermec Inc (Director · May 26, 2010 – Sep 17, 2013 · Past)
Director · Since at least Apr 25, 2017
Andrew J Last
Other companies: Insight Molecular Diagnostics Inc. (Director · Since at least Dec 30, 2015); Precigen, Inc. (Chief Operating Officer · Aug 29, 2016 – Nov 13, 2017 · Past); Affymetrix Inc (EVP, Chief Operating Officer · Feb 24, 2010 – Mar 31, 2016 · Past)
EVP, Chief Operating Officer · Apr 22, 2019 – Sep 6, 2024 · Past
Jeffrey L. Edwards
Other companies: Kyntra Bio, Inc. (Director · Since at least Oct 28, 2015); Lifecore Biomedical, Inc. (Director · Oct 14, 2020 – Jul 8, 2024 · Past); Clearside Biomedical Inc (Director · Sep 26, 2018 – Jun 20, 2024 · Past)
Director · Since at least Apr 25, 2017
Deborah Neff
Other companies: Cytek Biosciences, Inc. (Lead Independent Director · Since at least Jun 1, 2022); Advanced Medical Optics Inc (Director · May 25, 2006 – May 29, 2008 · Past)
Director · Oct 26, 2011 – Oct 26, 2011 · Past
Joel McComb
Other companies: Avid Bioservices Inc (Director · Nov 27, 2017 – Dec 14, 2018 · Past); Illumina, Inc. (Sr VP & General Manager · Mar 17, 2008 – Jan 28, 2010 · Past)
Director · Jul 23, 2014 – Jul 23, 2014 · Past
Roop Kalyan Lakkaraju
Other companies: Infinera Corporation (Director · May 19, 2022 – Feb 28, 2025 · Past); Benchmark Electronics, Inc. (EVP, Chief Financial Officer · Feb 22, 2022 – Feb 23, 2024 · Past)
EVP, Chief Financial Officer · Since at least Apr 15, 2024
Annette Tumolo
Other companies: Telesis Bio, Inc. (Director · Jul 6, 2023 – Jul 6, 2023 · Past)
Executive Vice President · Sep 18, 2017 – Nov 11, 2021 · Past
Jonathan P DiVincenzo
Other companies: Labcorp Holdings Inc. (EVP, Pres, Central Labs & Intl · May 1, 2023 – Mar 27, 2024 · Past)
President & COO · Since at least Sep 9, 2024
All 32 people
PersonSeat
Melinda Litherland Pei
Other companies: Rapid Micro Biosystems, Inc. (Director · Since at least Jul 14, 2021)
Director · Since at least Apr 25, 2017
Ajit RamalingamSVP, Chief Accounting Officer · Apr 29, 2022 – Sep 1, 2023 · Past
Alice N SchwartzDirector · Dec 3, 2019 – Nov 9, 2021 · Past
Anna GralinskaCorporate Communications · Since at least Sep 16, 2026
Arnold A PinkstonDirector · Since at least Sep 6, 2024
Colleen CoreyEVP, Global Human Resources · Since at least Apr 26, 2023
Dara WrightEVP, President, CDG · Dec 16, 2019 – Dec 16, 2023 · Past
Diane DahowskiEVP, Global Supply Chain · Apr 27, 2022 – Sep 1, 2023 · Past
Edward ChungInvestor Relations · Since at least Feb 12, 2026
Eva Anette EngelhardtEVP, President, CDG · Since at least Jun 10, 2024
James BarryEVP, President, LSG · Since at least May 1, 2024
James BennettDirector · Mar 31, 2006 – Nov 19, 2010 · Past
Michael CrowleyEVP, GBL Commercial Operations · Nov 28, 2023 – Mar 14, 2025 · Past
Norman SchwartzCEO · Since at least Aug 4, 2026
Rajat MehtaEVP, GBL Commercial Operations · Since at least Aug 4, 2025
Ronald W HuttonVice President and Treasurer · Jun 10, 2010 – Sep 11, 2020 · Past
Ruben ArguetaInvestor Relations · Since at least Sep 16, 2026
Sanford WadlerVP, General Counsel, Secretary · Jun 10, 2009 – Nov 4, 2012 · Past
Schwartz AllisonDirector · Since at least Apr 26, 2022
Sedat EvranEVP, Global Supply Chain · Since at least Sep 5, 2023
Tania DevilliersINT PRIN ACCTG OFC · Sep 19, 2023 – Sep 19, 2023 · Past
Timothy S ErnstEVP, General Counsel & Sec · Jun 6, 2016 – Mar 8, 2024 · Past

Open People

Log in to ask 6ix AI your own questions about Bio-Rad Laboratories, Inc.